Search Results 71-80 of 19678 for Hepatitis C

  1. cancer and luck Archives - Mayo Clinic News Network

    one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even ...

  2. C Clinical Trials - Mayo Clinic Research

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  3. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying new ways to diagnose and treat hepatitis C, with particular emphasis on optimal antiviral therapy ...

  4. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...

  5. A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C - Mayo Clinic

    A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C · Overview · Participation ...

  6. 'Our goal is to achieve a world without viral hepatitis' - Mayo Clinic News Network

    In the U.S., the Centers for Disease Control and Prevention recommends screening all adults for hepatitis C and all people who were born or lived in a country ...

  7. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  8. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  9. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  10. cirrhosis Archives - Mayo Clinic News Network

    Hepatitis C is a viral infection that causes liver inflammation. It is spread through contact with blood that's infected with the virus. Numerous factors have ...